Geode Capital Management, LLC Taysha Gene Therapies, Inc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,562,758 shares of TSHA stock, worth $7.16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,562,758
Previous 2,880,485
23.69%
Holding current value
$7.16 Million
Previous $6.45 Million
10.99%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding TSHA
# of Institutions
119Shares Held
136MCall Options Held
25.9KPut Options Held
24K-
Avoro Capital Advisors LLC New York, NY18.7MShares$37.5 Million0.56% of portfolio
-
Rtw Investments, LP New York, NY14.9MShares$30 Million0.48% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$23.6 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$21.9 Million0.3% of portfolio
-
Vr Adviser, LLC New York, NY9MShares$18.1 Million1.87% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $97.2M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...